Rare diseases
Investigational molecules
Locations
Back to Bulgaria4 clinical trials in Stamboliyski, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
BulgariaBulgariaBulgariaBulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on evaluating MF59-adjuvanted subunit inactivated influenza vaccines compared to traditional non-adjuvanted versions for older adults. The research aims to enhance protection against influenza strains.
These trials specifically target populations aged 65 and above to improve vaccine effectiveness.
Innovative research examining inclisiran for preventing cardiovascular events in patients with established vascular disease. The studies focus on reducing major adverse cardiovascular events.
Research targets patients with atherosclerotic cardiovascular disease and specific LDL-C levels.
Advanced research comparing mRNA-1010 candidate influenza vaccine with licensed alternatives. The studies evaluate new approaches to influenza prevention using messenger RNA technology.
This research specifically focuses on adults aged 50 and above, examining both safety and effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
